Terms: = Endocrine gland cancer AND CREB1, ENSG00000118260, 1385
34 results:
1. The creb1/WNK1 axis promotes the tumorigenesis of ovarian cancer via regulating HIF-1.
Ma Y; Zong H; Pan P; Shang H; Yang X
Exp Cell Res; 2024 May; 438(1):114006. PubMed ID: 38599542
[TBL] [Abstract] [Full Text] [Related]
2. LINC02454 promotes thyroid carcinoma progression via upregulating HMGA2 through creb1.
Cao Y; Li J; Du Y; Sun Y; Liu L; Fang H; Liang Y; Mao S
FASEB J; 2023 Dec; 37(12):e23288. PubMed ID: 37997502
[TBL] [Abstract] [Full Text] [Related]
3. MEX3A induces the development of thyroid cancer via targeting creb1.
Feng G; Wang P; Zhang H; Cheng S; Xing Y; Wang Y
Cell Biol Int; 2023 Nov; 47(11):1843-1853. PubMed ID: 37529875
[TBL] [Abstract] [Full Text] [Related]
4. Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts.
Agaimy A; Kasajima A; Stoehr R; Haller F; Schubart C; Tögel L; Pfarr N; von Werder A; Pavel ME; Sessa F; Uccella S; La Rosa S; Klöppel G
Virchows Arch; 2023 Mar; 482(3):507-516. PubMed ID: 36690805
[TBL] [Abstract] [Full Text] [Related]
5. Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations.
Whitmer D; Phay JE; Holt S; O'Donnell B; Nguyen J; Joseph D; Chi A; Wu S; Hao Y; Huang J; Klopper JP; Kloos RT; Kennedy GC; Shin J
Front Endocrinol (Lausanne); 2022; 13():1073592. PubMed ID: 36619548
[TBL] [Abstract] [Full Text] [Related]
6. Endoplasmic stress-inducing variants in CPB1 and CPA1 and risk of pancreatic cancer: A case-control study and meta-analysis.
Kawamoto M; Kohi S; Abe T; Dbouk M; Macgregor-Das A; Koi C; Song KB; Borges M; Sugimine R; Laheru D; Hruban RH; Roberts N; Klein AP; Goggins M
Int J Cancer; 2022 Apr; 150(7):1123-1133. PubMed ID: 34817877
[TBL] [Abstract] [Full Text] [Related]
7. The risk of pancreatic adenocarcinoma following SARS-CoV family infection.
Ebrahimi Sadrabadi A; Bereimipour A; Jalili A; Gholipurmalekabadi M; Farhadihosseinabadi B; Seifalian AM
Sci Rep; 2021 Jun; 11(1):12948. PubMed ID: 34155232
[TBL] [Abstract] [Full Text] [Related]
8. Oncogenic
Kim MP; Li X; Deng J; Zhang Y; Dai B; Allton KL; Hughes TG; Siangco C; Augustine JJ; Kang Y; McDaniel JM; Xiong S; Koay EJ; McAllister F; Bristow CA; Heffernan TP; Maitra A; Liu B; Barton MC; Wasylishen AR; Fleming JB; Lozano G
Cancer Discov; 2021 Aug; 11(8):2094-2111. PubMed ID: 33839689
[TBL] [Abstract] [Full Text] [Related]
9. Expression of CAMK1 and its association with clinicopathologic characteristics in pancreatic cancer.
Lei Y; Yu T; Li C; Li J; Liang Y; Wang X; Chen Y; Wang X
J Cell Mol Med; 2021 Jan; 25(2):1198-1206. PubMed ID: 33342045
[TBL] [Abstract] [Full Text] [Related]
10. Multi-Omics Analysis Identifying Key Biomarkers in Ovarian cancer.
Li JY; Li CJ; Lin LT; Tsui KH
Cancer Control; 2020; 27(1):1073274820976671. PubMed ID: 33297760
[TBL] [Abstract] [Full Text] [Related]
11. Identification of new candidate genes and signalling pathways associated with the development of neuroendocrine pancreatic tumours based on next generation sequencing data.
Kit OI; Trifanov VS; Petrusenko NA; Gvaldin DY; Kutilin DS; Timoshkina NN
Mol Biol Rep; 2020 Jun; 47(6):4233-4243. PubMed ID: 32451928
[TBL] [Abstract] [Full Text] [Related]
12. Common cancer biomarkers of breast and ovarian types identified through artificial intelligence.
Pawar S; Liew TO; Stanam A; Lahiri C
Chem Biol Drug Des; 2020 Sep; 96(3):995-1004. PubMed ID: 32410355
[TBL] [Abstract] [Full Text] [Related]
13. Accuracy of Grading in Pancreatic Neuroendocrine Neoplasms and Effect on Survival Estimates: An Institutional Experience.
Trikalinos NA; Chatterjee D; Lee J; Liu J; Williams G; Hawkins W; Hammill C
Ann Surg Oncol; 2020 Sep; 27(9):3542-3550. PubMed ID: 32206954
[TBL] [Abstract] [Full Text] [Related]
14. Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey.
Pezzilli R; Buscarini E; Pollini T; Bonamini D; Marchegiani G; Crippa S; Belfiori G; Sperti C; Moletta L; Pozza G; De Nucci G; Manes G; Mandelli ED; Casadei R; Ricci C; Alicante S; Vattiato C; Carrara S; Di Leo M; Fabbri C; Giovanelli S; Barresi L; Tacelli M; Mirante VG; Conigliaro R; Antonini F; Macarri G; Frulloni L; De Marchi G; Sassatelli R; Cecinato P; Del Vecchio Blanco G; Galli A; Pezzullo A; Fantin A; Graffeo M; Frego M; Stillittano D; Monica F; Germanà B; Capurso G; Quartini M; Veneroni L; Cannizzaro R; Falconi M
Dig Liver Dis; 2020 May; 52(5):547-554. PubMed ID: 32122771
[TBL] [Abstract] [Full Text] [Related]
15. Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.
Hossain MA; Asa TA; Rahman MM; Uddin S; Moustafa AA; Quinn JMW; Moni MA
Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32093341
[TBL] [Abstract] [Full Text] [Related]
16. Transcriptional Characterization of Stage I Epithelial Ovarian cancer: A Multicentric Study.
Calura E; Ciciani M; Sambugaro A; Paracchini L; Benvenuto G; Milite S; Martini P; Beltrame L; Zane F; Fruscio R; Marchette MD; Borella F; Tognon G; Ravaggi A; Katsaros D; Bignotti E; Odicino F; D'Incalci M; Marchini S; Romualdi C
Cells; 2019 Dec; 8(12):. PubMed ID: 31805750
[TBL] [Abstract] [Full Text] [Related]
17. Identification and interaction analysis of key miRNAs in medullary thyroid carcinoma by bioinformatics analysis.
Zhang L; Lu D; Liu M; Zhang M; Peng Q
Mol Med Rep; 2019 Sep; 20(3):2316-2324. PubMed ID: 31322209
[TBL] [Abstract] [Full Text] [Related]
18. creb1 induced lncRNA HAS2-AS1 promotes epithelial ovarian cancer proliferation and invasion via the miR-466/RUNX2 axis.
Tong L; Wang Y; Ao Y; Sun X
Biomed Pharmacother; 2019 Jul; 115():108891. PubMed ID: 31082772
[TBL] [Abstract] [Full Text] [Related]
19. Solid stress-induced migration is mediated by GDF15 through Akt pathway activation in pancreatic cancer cells.
Kalli M; Minia A; Pliaka V; Fotis C; Alexopoulos LG; Stylianopoulos T
Sci Rep; 2019 Jan; 9(1):978. PubMed ID: 30700740
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathologic Features and Risk Factors for Recurrence of Mucinous Borderline Ovarian Tumors: A Retrospective Study With Follow-up of More Than 10 Years.
Sun L; Li N; Song Y; Wang G; Zhao Z; Wu L
Int J Gynecol Cancer; 2018 Nov; 28(9):1643-1649. PubMed ID: 30365456
[TBL] [Abstract] [Full Text] [Related]
[Next]
